Rate of engraftment
Showing 1 - 25 of >10,000
Leukemia, Stem Cell Transplant, Cord Blood Trial in Guangzhou (applying of FLU+CY post-HSCT)
Recruiting
- Leukemia
- +2 more
- applying of FLU+CY post-HSCT
-
Guangzhou, Guangdong, ChinaNanfang Hospital
Nov 23, 2023
Hematopoietic Malignancy, Relapse/Recurrence, Hematopoietic Stem Cell Transplantation Trial in Suzhou (Umbilical Cord Blood
Recruiting
- Hematopoietic Malignancy
- +2 more
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Nov 6, 2023
Stem Cells Mobilization, colLection and Engraftment in Newly
Recruiting
- Multiple Myeloma
- +3 more
-
Rome, ItalyFondazione Policlinico Universitario A.Gemelli IRCCS
Apr 28, 2023
Hematopoietic Stem Cell Transplantation, Malignant Hematological Diseases Trial in Suzhou (Umbilical Cord Blood Transplantation)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Malignant Hematological Diseases
- Umbilical Cord Blood Transplantation
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow university
Jul 3, 2023
Allogeneic Hematopoietic Cell Transplantation Trial in Cleveland (Nicotinamide riboside (NR))
Recruiting
- Allogeneic Hematopoietic Cell Transplantation
- Nicotinamide riboside (NR)
-
Cleveland, OhioCleveland Clinic, Case Comprehensive Cancer Center
Jan 17, 2023
Bone Marrow Transplant Complications, Fatigue, Vital Signs Trial in Ankara (Reiki)
Recruiting
- Bone Marrow Transplant Complications
- +3 more
- Reiki
-
Ankara, None Selected, TurkeyNursemin Ünal
Jan 19, 2023
Myeloid Hematological Malignancies Trial in Houston (Busulfan, Cyclophosphamide, Fludarabine)
Completed
- Myeloid Hematological Malignancies
- Busulfan
- +3 more
-
Houston, TexasTexas Children's Hospital
May 13, 2022
Acute Myeloid Leukemia Trial in Saint Louis (Graft cell infusion, Tacrolimus, Mycophenolate mofetil)
Recruiting
- Acute Myeloid Leukemia
- Graft cell infusion
- +6 more
-
Saint Louis, MissouriWashington University School of Medicine
Jan 29, 2023
Leukemia, Lymphoma Trial in Memphis (radiation, drug, biological, device)
Completed
- Leukemia
- Lymphoma
- Total Lymphoid Irradiation
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 28, 2022
Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome
Not yet recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 5, 2023
Hematological Disease, Allogeneic Hematopoietic Stem Cell Transplantation Trial in Tianjin (Hetrombopag, )
Recruiting
- Hematological Disease
- Allogeneic Hematopoietic Stem Cell Transplantation
- Hetrombopag
- placebo
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital, Chinese Acade
Feb 6, 2023
B-cell NHL, CLL Trial (CARCIK-CD19)
Not yet recruiting
- B-cell NHL
- CLL
- CARCIK-CD19
- (no location specified)
May 19, 2023
Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure Trial in Baltimore (Alemtuzumab, Fludarabine,
Recruiting
- Primary Immune Deficiency Disorder
- +2 more
- Alemtuzumab
- +6 more
-
Baltimore, MarylandJohns Hopkins University
Oct 20, 2022
Bone Marrow Failure Syndromes Trial in Philadelphia (MRD-BMT with Fludarabine-based RIC for Acquired AA, MRD-BMT with
Recruiting
- Bone Marrow Failure Syndromes
- MRD-BMT with Fludarabine-based RIC for Acquired AA
- +2 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
May 6, 2022
Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Memphis (drug, radiation, device, biological)
Recruiting
- Aplastic Anemia
- Bone Marrow Failure Syndrome
- Anti-Thymocyte Globulin (Rabbit)
- +8 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Aug 26, 2022
Immunodeficiencies Trial in Philadelphia (CliniMACs)
Active, not recruiting
- Immunodeficiencies
- CliniMACs
-
Philadelphia, PennsylvaniaThe Children's Hospital of Philadelphia
Mar 1, 2022
Ulcerative Colitis Trial in Minneapolis (Fecal microbiota, Placebo)
Active, not recruiting
- Ulcerative Colitis
- Fecal microbiota
- Placebo
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 14, 2022
Hematologic Disorders Trial in Aurora (Miltenyi CliniMACS® CD34 Reagent System)
Recruiting
- Hematologic Disorders
- Miltenyi CliniMACS® CD34 Reagent System
-
Aurora, ColoradoUniversity of Colorado
Feb 22, 2022
AML, ALL, Lymphoid Malignancies Trial in Birmingham (Infusion of CD34 selected hematopoietic stem cells)
Not yet recruiting
- AML
- +5 more
- Infusion of CD34 selected hematopoietic stem cells
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Sep 14, 2023
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Cancer Metastatic, Prostate Cancer, Breast Cancer Trial in Pierre-Bénite (Patient sampling.)
Not yet recruiting
- Cancer Metastatic
- +5 more
- Patient sampling.
-
Pierre-Bénite, France
- +1 more
Jul 22, 2022
T-cell Non-Hodgkin Lymphoma, Lymphoma, Extranodal NK-T-Cell Trial in Busan, Daegu (Busulfan, Fludarabine)
Recruiting
- T-cell Non-Hodgkin Lymphoma
- Lymphoma, Extranodal NK-T-Cell
-
Busan, Korea, Republic of
- +1 more
Aug 17, 2022
Hematologic Tumors Trial in Milan (Cyclophosphamide, Hematopoietic Stem Cell Transplantation,)
Recruiting
- Hematologic Neoplasms
- Cyclophosphamide
- Hematopoietic Stem Cell Transplantation,
-
Milan, ItalyEuropean Institute of Oncology
Sep 24, 2021